UA

Ubed Ahemad Khan Nisar Ahemad Khan

Active Director Additional Director DIN 11237480
DIN 11237480 First appointment Oct 2025 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Oct 2025
Shareholding value •••• Premium profile

About Ubed Ahemad Khan Nisar Ahemad Khan

Data last updated:

Ubed Ahemad Khan Nisar Ahemad Khan is an Additional Director at Dymocare Pharmaceutical Private Limited (since 2025). The company operates in Pharma. Dymocare Pharmaceutical Private Limited reported revenue of ₹66.7 Lakh (FY 2025).

DIN 11237480
Primary Designation Additional Director
Industry Pharma
First Appointment 09 Oct 2025
Largest company Dymocare Pharmaceutical Private Limited · ₹66.7 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Additional Director09 Oct 2025₹66.7 Lakh (FY 2025)Active

Board colleagues of Ubed Ahemad Khan Nisar Ahemad Khan

Directorship timeline

Open interactive timeline →
Dymocare Pharmaceutical Private Limited
Premium access

Shareholding and investment profile for Ubed Ahemad Khan Nisar Ahemad Khan

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ubed Ahemad Khan Nisar Ahemad Khan

Ubed Ahemad Khan Nisar Ahemad Khan currently holds 1 directorship: Dymocare Pharmaceutical Private Limited (Additional Director, since 09 Oct 2025, revenue ₹66.7 Lakh (FY 2025)).

Ubed Ahemad Khan Nisar Ahemad Khan was first appointed on 09 Oct 2025 as Additional Director at Dymocare Pharmaceutical Private Limited.

The current boards of Ubed Ahemad Khan Nisar Ahemad Khan's companies include Aayesha Tarrannum Abdul Jabbar (Dymocare Pharmaceutical Private Limited), Shaikh Mushtaq Shaikh Mukhtar (Dymocare Pharmaceutical Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available